- PRA052 is the second clinical candidate identified using the Prometheus360™ platform with one of the strongest genetic associations to IBD and is linked to a broad range of immune-mediated diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback